PIM
IDXX icon

Plato Investment Management’s Idexx Laboratories IDXX Stock Holding History

Plato Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Sell
2,836
-253
-8% -$142K 0.08% 216
2026
Q1 		$1.74M Hold
3,089
– – 0.12% 183
2025
Q4 		$2.1M Hold
3,089
– – 0.14% 157
2025
Q3 		$1.96M Hold
3,089
– – 0.13% 170
2025
Q2 		$1.65M Buy
3,089
+2
+0.1% +$956 0.12% 179
2025
Q1 		$1.31M Buy
3,087
+835
+37% +$363K 0.11% 204
2024
Q4 		$934K Buy
2,252
+819
+57% +$359K 0.07% 262
2024
Q3 		$723K Sell
1,433
-22
-2% -$10.7K 0.06% 282
2024
Q2 		$709K Sell
1,455
-54
-4% -$27.1K 0.07% 245
2024
Q1 		$815K Buy
1,509
+1,424
+1,675% +$778K 0.08% 225
2023
Q4 		$47.2K Buy
+85
New +$39.9K 0.06% 233

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Plato Investment Management's IDXX Position: Q2 2026 in Review

Plato Investment Management reduced its Idexx Laboratories (IDXX) stake by 8.2% in Q2 2026, selling an estimated $142K and leaving 2,836 shares worth $1.48M. The position accounts for 0.08% of the portfolio, ranked #216.

Plato Investment Management first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.1M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Plato Investment Management held 2,836 shares of Idexx Laboratories worth $1.48M as of Q2 2026.
  • Plato Investment Management sold 253 Idexx Laboratories shares in Q2 2026, an estimated $142K.
  • Idexx Laboratories made up 0.08% of Plato Investment Management's portfolio in Q2 2026, its #216 holding.
  • Plato Investment Management first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Plato Investment Management's Idexx Laboratories position peaked at $2.1M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.